☆ 4.2 Review

The pharmacotherapeutic management of premenstrual dysphoric disorder

EXPERT OPINION ON PHARMACOTHERAPY (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Public, Environmental & Occupational Health

Patient Experiences of Health Care Providers in Premenstrual Dysphoric Disorder: Examining the Role of Provider Specialty

Liisa Hantsoo et al.

Summary: This study aimed to examine patients' experiences with different health care specialties when seeking care for PMDD symptoms, finding that different providers have different strengths in assessing and treating PMDD. Patients reported varied interactions and experiences with different medical professionals, highlighting the importance of tailored care for individuals with PMDD.

JOURNAL OF WOMENS HEALTH (2022)

添加到收藏夹

Article Public, Environmental & Occupational Health

A DSM-5-based tool to monitor concurrent mood and premenstrual symptoms: the McMaster Premenstrual and Mood Symptom Scale (MAC-PMSS)

Benicio N. Frey et al.

Summary: In this study, a new DSM-5-based questionnaire was developed to monitor concurrent premenstrual and mood symptoms. Results showed that the questionnaire had strong correlations with other measurement tools, indicating its reliability.

BMC WOMENS HEALTH (2022)

添加到收藏夹

Article Psychiatry

Ulipristal Acetate for Treatment of Premenstrual Dysphoric Disorder: A Proof-of-Concept Randomized Controlled Trial

Erika Comasco et al.

Summary: The study investigated the potential treatment of continuous treatment with a selective progesterone receptor modulator, ulipristal acetate (UPA), for premenstrual dysphoric disorder (PMDD). Results showed that the UPA group demonstrated a significant improvement in DRSP scores compared to the placebo group, particularly in depressive and anger/irritability symptoms.

AMERICAN JOURNAL OF PSYCHIATRY (2021)

添加到收藏夹

Review Clinical Neurology

Suicidality in patients with premenstrual dysphoric disorder-A systematic review and meta-analysis

Haohao Yan et al.

Summary: The study found that PMDD patients have a higher risk of suicidal ideation, suicide attempt, and suicide plan. Clinicians treating PMDD patients should be vigilant about signs of suicide ideation and behavior to implement better treatment and preventive measures.

JOURNAL OF AFFECTIVE DISORDERS (2021)

添加到收藏夹

Review Psychiatry

Premenstrual Mood Symptoms in the Perimenopause

Bethany Sander et al.

Summary: Recent findings suggest that early menopause transition may exacerbate existing MRMDs due to hormonal changes, leading to depressive mood in some women. There is also evidence that some women with MRMD may have increased mood sensitivity to ovarian hormone withdrawal during late menopause transition and early postmenopausal phase. Further research is needed to clarify the trajectory of premenstrual dysphoria in the menopause transition and to be vigilant for potential worsening of symptoms in perimenopause for women with past or current premenstrual dysphoric disorder.

CURRENT PSYCHIATRY REPORTS (2021)

添加到收藏夹

Editorial Material Medicine, General & Internal

Understanding menstrual cycle effects on suicide will require prospective studies of suicidal thoughts and behaviors in premenstrual disorders

Sarah A. Owens et al.

BMC MEDICINE (2021)

添加到收藏夹

Review Public, Environmental & Occupational Health

Suicidal Risk in Women with Premenstrual Syndrome and Premenstrual Dysphoric Disorder: A Systematic Review and Meta-Analysis

Divya Prasad et al.

Summary: This study found that women with PMDD and PMS are more likely to have suicidal ideation and risk of suicide. Routine suicidal risk assessments are recommended for women with moderate-to-severe premenstrual disturbances, and psychosocial treatments for PMS/PMDD should target suicidality to minimize risk and improve well-being.

JOURNAL OF WOMENS HEALTH (2021)

添加到收藏夹

Article Endocrinology & Metabolism

A randomized, double-blind study on efficacy and safety of sepranolone in premenstrual dysphoric disorder

Torbjorn Backstrom et al.

Summary: The study aimed to investigate the efficacy of the GABA(A) receptor modulating steroid antagonist sepranolone in treating PMDD. Results showed that the 10 mg dosage of sepranolone significantly improved symptoms, impairment, and distress in patients.

PSYCHONEUROENDOCRINOLOGY (2021)

添加到收藏夹

Review Psychiatry

Comorbid Premenstrual Dysphoric Disorder and Bipolar Disorder: A Review

Anastasiya Slyepchenko et al.

Summary: Bipolar disorder presents differently in females compared to males, with characteristics such as more depressive episodes and rapid cycling. Comorbid PMDD with BD in females may lead to a more complex illness course and unique neurobiological correlates, posing challenges in treatment.

FRONTIERS IN PSYCHIATRY (2021)

添加到收藏夹

Article Medicine, General & Internal

Premenstrual Dysphoric Disorder

Teresa Lanza di Scalea et al.

MEDICAL CLINICS OF NORTH AMERICA (2019)

添加到收藏夹

Review Psychiatry

Hormonal Contraceptives and Mood: Review of the Literature and Implications for Future Research

Thalia Robakis et al.

CURRENT PSYCHIATRY REPORTS (2019)

添加到收藏夹

Review Integrative & Complementary Medicine

Vitex agnus-castus in premenstrual syndrome: A meta-analysis of double-blind randomised controlled trials

Dezso Csupor et al.

COMPLEMENTARY THERAPIES IN MEDICINE (2019)

添加到收藏夹

Article Psychiatry

Menstrual Cycle Effects on Mental Health Outcomes: A Meta-Analysis

Daisung Jang et al.

ARCHIVES OF SUICIDE RESEARCH (2019)

添加到收藏夹

Review Obstetrics & Gynecology

Premenstrual disorders

Kimberly Ann Yonkers et al.

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2018)

添加到收藏夹

Editorial Material Obstetrics & Gynecology

Liver injury and ulipristal acetate: an overstated tragedy?

Jacques Donnez

FERTILITY AND STERILITY (2018)

添加到收藏夹

Article Pharmacology & Pharmacy

Treatment of Premenstrual Breakthrough of Depression With Adjunctive Oral Contraceptive Pills Compared With Placebo

Whitney Peters et al.

JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2017)

添加到收藏夹

Article Endocrinology & Metabolism

Combined oral contraceptive use is associated with both improvement and worsening of mood in the different phases of the treatment cycle-A double-blind, placebo-controlled randomized trial

Cecilia Lundin et al.

PSYCHONEUROENDOCRINOLOGY (2017)

添加到收藏夹

Review Psychiatry

Vitex agnus castus for premenstrual syndrome and premenstrual dysphoric disorder: a systematic review

Raphael O. Cerqueira et al.

ARCHIVES OF WOMENS MENTAL HEALTH (2017)

添加到收藏夹

Article Psychiatry

Premenstrual Dysphoric Disorder Symptoms Following Ovarian Suppression: Triggered by Change in Ovarian Steroid Levels But Not Continuous Stable Levels

Peter J. Schmidt et al.

AMERICAN JOURNAL OF PSYCHIATRY (2017)

添加到收藏夹

Review Obstetrics & Gynecology

The treatment of premenstrual syndrome with preparations of Vitex agnus castus: a systematic review and meta-analysis

Saskia Verkaik et al.

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2017)

添加到收藏夹

Article Psychiatry

Toward the Reliable Diagnosis of DSM-5 Premenstrual Dysphoric Disorder: The Carolina Premenstrual Assessment Scoring System (C-PASS)

Tory A. Eisenlohr-Moul et al.

AMERICAN JOURNAL OF PSYCHIATRY (2017)

添加到收藏夹

Article Neurosciences

5α-Reductase Inhibition Prevents the Luteal Phase Increase in Plasma Allopregnanolone Levels and Mitigates Symptoms in Women with Premenstrual Dysphoric Disorder

Pedro E. Martinez et al.

NEUROPSYCHOPHARMACOLOGY (2016)

添加到收藏夹

Article Psychiatry

Fourth consensus of the International Society for Premenstrual Disorders (ISPMD): auditable standards for diagnosis and management of premenstrual disorder

Elgerta Ismaili et al.

ARCHIVES OF WOMENS MENTAL HEALTH (2016)

添加到收藏夹

Article Obstetrics & Gynecology

Management of Premenstrual Syndrome

BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2016)

添加到收藏夹

Review Clinical Neurology

Premenstrual Dysphoric Disorder Without Comorbid Psychiatric Conditions: A Systematic Review of Therapeutic Options

Gianna Sepede et al.

CLINICAL NEUROPHARMACOLOGY (2016)

添加到收藏夹

Editorial Material Neurosciences

Treating comorbid premenstrual dysphoric disorder in women with bipolar disorder

Mara Smith et al.

JOURNAL OF PSYCHIATRY & NEUROSCIENCE (2016)

添加到收藏夹

Article Psychiatry

Effects of Estradiol Withdrawal on Mood in Women With Past Perimenopausal Depression A Randomized Clinical Trial

Peter J. Schmidt et al.

JAMA PSYCHIATRY (2015)

添加到收藏夹

Article Psychiatry

Symptom-Onset Dosing of Sertraline for the Treatment of Premenstrual Dysphoric Disorder A Randomized Clinical Trial

Kimberly A. Yonkers et al.

JAMA PSYCHIATRY (2015)

添加到收藏夹

Review Obstetrics & Gynecology

Selective progesterone receptor modulators

Lucy H. R. Whitaker et al.

CURRENT OPINION IN OBSTETRICS & GYNECOLOGY (2014)

添加到收藏夹

Review Endocrinology & Metabolism

Sex differences in anxiety and depression clinical perspectives

Margaret Altemus et al.

FRONTIERS IN NEUROENDOCRINOLOGY (2014)

添加到收藏夹

Article Psychiatry

ISPMD consensus on the management of premenstrual disorders

Tracy Nevatte et al.

ARCHIVES OF WOMENS MENTAL HEALTH (2013)

添加到收藏夹

Review Obstetrics & Gynecology

Treatment of premenstrual dysphoric disorder

Andrea J. Rapkin et al.

WOMENS HEALTH (2013)

添加到收藏夹

Article Obstetrics & Gynecology

Continuous oral levonorgestrel/ethinyl estradiol for treating premenstrual dysphoric disorder

Uriel Halbreich et al.

CONTRACEPTION (2012)

添加到收藏夹

Article Psychology, Clinical

Cognitive-Behavioral and Pharmacological Interventions for Premenstrual Syndrome or Premenstrual Dysphoric Disorder: A Meta-Analysis

Maria Kleinstaeuber et al.

JOURNAL OF CLINICAL PSYCHOLOGY IN MEDICAL SETTINGS (2012)

添加到收藏夹

Article Psychiatry

The premenstrual symptoms screening tool revised for adolescents (PSST-A): prevalence of severe PMS and premenstrual dysphoric disorder in adolescents

Meir Steiner et al.

ARCHIVES OF WOMENS MENTAL HEALTH (2011)

添加到收藏夹

Article Public, Environmental & Occupational Health

The interrelation between premenstrual syndrome and major depression: Results from a population-based sample

Christine Forrester-Knauss et al.

BMC PUBLIC HEALTH (2011)

添加到收藏夹

Article Psychiatry

Cognitive-behavioral therapy for premenstrual syndrome and premenstrual dysphoric disorder: a systematic review

M. Kathleen B. Lustyk et al.

ARCHIVES OF WOMENS MENTAL HEALTH (2009)

添加到收藏夹

Article Chemistry, Medicinal

Antiinflammatory and Lipoxygenase Inhibitory Compounds from Vitex agnus-castus

M. Iqbal Choudhary et al.

PHYTOTHERAPY RESEARCH (2009)

添加到收藏夹

Article Psychiatry

Psychological Intervention for Premenstrual Syndrome: A Meta-Analysis of Randomized Controlled Trials

Jason W. Busse et al.

PSYCHOTHERAPY AND PSYCHOSOMATICS (2009)

添加到收藏夹

Review Medicine, General & Internal

Selective serotonin reuptake inhibitors for premenstrual syndrome

Julie Brown et al.

COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2009)

添加到收藏夹

Article Pharmacology & Pharmacy

Escitalopram administered in the luteal phase exerts a marked and dose-dependent effect in premenstrual dysphoric disorder

Elias Eriksson et al.

JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2008)

添加到收藏夹

Article Obstetrics & Gynecology

Selective serotonin reuptake inhibitors for premenstrual syndrome and premenstrual dysphoric disorder - A meta-analyslis

Nirav R. Shah et al.

OBSTETRICS AND GYNECOLOGY (2008)

添加到收藏夹

Review Endocrinology & Metabolism

From menarche to menopause: Exploring the underlying biology of depression in women experiencing hormonal changes

Darlene Deecher et al.

PSYCHONEUROENDOCRINOLOGY (2008)

添加到收藏夹

Article Psychology, Clinical

Treatment of premenstrual worsening of depression with adjunctive oral contraceptive pills: A preliminary report

Hadine Joffe et al.

JOURNAL OF CLINICAL PSYCHIATRY (2007)

添加到收藏夹

Article Neurosciences

Placebo-controlled trial comparing intermittent and continuous paroxetine in premenstrual dysphoric disorder

Mikael Landen et al.

NEUROPSYCHOPHARMACOLOGY (2007)

添加到收藏夹

Article Psychiatry

Risk factors for early postpartum depressive symptoms

M Bloch et al.

GENERAL HOSPITAL PSYCHIATRY (2006)

添加到收藏夹

Article Public, Environmental & Occupational Health

Expert guidelines for the treatment of severe PMS, PMDD, and comorbidities: the role of SSRIs

M Steiner et al.

JOURNAL OF WOMENS HEALTH (2006)

添加到收藏夹

Article Obstetrics & Gynecology

Treatment of premenstrual dysphoric disorder with a new drospirenone-containing oral contraceptive formulation

TB Pearlstein et al.

CONTRACEPTION (2005)

添加到收藏夹

Article Psychiatry

Daily Record of Severity of Problems (DRSP): reliability and validity

J Endicott et al.

ARCHIVES OF WOMENS MENTAL HEALTH (2005)

添加到收藏夹

Article Clinical Neurology

Epidemiology of women and depression

RC Kessler

JOURNAL OF AFFECTIVE DISORDERS (2003)

添加到收藏夹

Article Psychology, Clinical

Prevalence, incidence and stability of premenstrual dysphoric disorder in the community

HU Wittchen et al.

PSYCHOLOGICAL MEDICINE (2002)

添加到收藏夹

Article Psychiatry

Effects of gonadal steroids in women with a history of postpartum depression

M Bloch et al.

AMERICAN JOURNAL OF PSYCHIATRY (2000)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.